108
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Impact of Monocyte to High-Density Lipoprotein Ratio on Reduced Renal Function: Insights From A Large Population

, , , , &
Pages 773-783 | Received 07 Nov 2018, Accepted 29 Mar 2019, Published online: 03 Jun 2019

References

  • Webster A , NaglerE, MortonR, MassonP. Chronic kidney disease. Lancet389(10075), 1238–1252 (2017).
  • Nugent R , FathimaS, FeiglA, ChyungD. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron. Clin. Pract.118(3), c269–c277 (2011).
  • Ayodele O , AlebiosuC. Burden of chronic kidney disease: an international perspective. Adv. Chronic Kidney Dis.17(3), 215–224 (2010).
  • Zhang L , WangF, WangLet al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet379(9818), 815–822 (2012).
  • Horowitz B , MiskulinD, ZagerP. Epidemiology of hypertension in CKD. Adv. Chronic Kidney Dis.22(2), 88–95 (2015).
  • Levey A , AstorB, StevensL, CoreshJ. Chronic kidney disease, diabetes, and hypertension: what’s in a name?Kidney Int.78(1), 19–22 (2010).
  • Vaziri N . Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. J. Ren. Nutr.20(Suppl. 5), S35–S43 (2010).
  • Dominguez JH , TangN, XuWet al. Studies of renal injury III: lipid-induced nephropathy in Type II diabetes. Kidney Int.57(1), 92–104 (2000).
  • Lavaud S , MichelO, Sassy-PrigentCet al. Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J. Am. Soc. Nephrol.7(12), 2604–2615 (1996).
  • Magil A . Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Mod. Pathol.12(1), 33–40 (1999).
  • Lee HS , KimYS. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int.54(3), 848–856 (1998).
  • Coll B , BetriuA, Martinez-AlonsoMet al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. Nephrol. Dial. Transplant.25(9), 3017–3025 (2010).
  • Leskinen Y , LehtimäkiT, LoimaalaAet al. Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. Atherosclerosis171(2), 295–302 (2003).
  • Cho I , MinHS, ChunEJet al. Coronary atherosclerosis detected by coronary CT angiography in asymptomatic subjects with early chronic kidney disease. Atherosclerosis208(2), 406–411 (2010).
  • Chonchol M , WhittleJ, DesbienA, OrnerMB, PetersenLA, KressinNR. Chronic kidney disease is associated with angiographic coronary artery disease. Am. J. Nephrol.28(2), 354–360 (2008).
  • Zhang L , ZhaoF, YangYet al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am. J. Kidney Dis.49(6), 786–792 (2007).
  • Kanbay M , SolakY, UnalHet al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol.46(8), 1619–1625 (2014).
  • Cagli K , TokD, TurakOet al. Monocyte count to high-density lipoprotein cholesterol ratio is associated with abdominal aortic aneurysm size. Biomark. Med.10(10), 1039–1047 (2016).
  • Vahit D , MehmetKA, SametY, HuseyinE. Assessment of monocyte to high-density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark. Med.11(7), 535–540 (2017).
  • Yilmaz S , AkbogaM, SenFet al. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark. Med.10(9), 959–966 (2016).
  • Ya G , QiuZ, TianrongP. Relation of monocyte/high-density lipoprotein cholesterol ratio with coronary artery disease in Type 2 diabetes mellitus. Clin. Lab.64(6), 901–906 (2018).
  • Wang H , SunY, LiZet al. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc. Disord.18(1), 62 (2018).
  • Shi WR , WangHY, ChenS, GuoXF, LiZ, SunYX. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study. Lipids Health Dis.17(1), 236 (2018).
  • Wang H , LiZ, GuoXet al. Contribution of non-traditional lipid profiles to reduced glomerular filtration rate in H-type hypertension population of rural China. Ann. Med.50(3), 249–259 (2018).
  • Levey A , StevensL, SchmidCet al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150(9), 604–612 (2009).
  • Stevens P , LevinA. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med.158(11), 825–830 (2013).
  • Chobanian A , BakrisG, BlackHet al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA289(19), 2560–2572 (2003).
  • American Diabetes Association . Classification and diagnosis of diabetes. Diabetes Care41(Suppl. 1), S13–S27 (2018).
  • Schaftenaar F , FrodermannV, KuiperJ, LutgensE. Atherosclerosis. Curr. Opin. Lipidol.27(3), 209–215 (2016).
  • Libby P , RidkerPM, HanssonGK, Leducq Transatlantic Network on A. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol.54(23), 2129–2138 (2009).
  • Cachofeiro V , GoicocheaM, de VinuesaSG, OubinaP, LaheraV, LunoJ. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int.111, S4–S9 (2008).
  • Swirski FK , NahrendorfM. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science339(6116), 161–166 (2013).
  • Simionescu M . Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol.27(2), 266–274 (2007).
  • Choi S , KimJ, LimSet al. Monocyte count as a predictor of cardiovascular mortality in older Korean people. Age Ageing46(3), 433–438 (2017).
  • Madjid M , AwanI, WillersonJT, CasscellsSW. Leukocyte count and coronary heart disease. J. Am. College Cardiol.44(10), 1945–1956 (2004).
  • Grosse GM , Schulz-SchaefferWJ, TeebkenOEet al. Monocyte subsets and related chemokines in carotid artery stenosis and ischemic stroke. Int. J. Mol. Sci.17(4), 433 (2016).
  • Rosenson RS , BrewerHB, Jr., AnsellBJet al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol.13(1), 48–60 (2016).
  • Maiolino G , RossittoG, CaielliP, BisogniV, RossiGP, CaloLA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm.2013, 714653 (2013).
  • Genest J , McPhersonR, FrohlichJet al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can. J. Cardiol.25(10), 567–579 (2009).
  • Murphy AJ , WoollardKJ, HoangAet al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol.28(11), 2071–2077 (2008).
  • Parthasarathy S , BarnettJ, FongLG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta1044(2), 275–283 (1990).
  • Yvan-Charvet L , PaglerT, GautierELet al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science328(5986), 1689–1693 (2010).
  • Di Angelantonio E , SarwarN, PerryPet al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA302(18), 1993–2000 (2009).
  • Reina S , LlabreM, AllisonMet al. HDL cholesterol and stroke risk: the multi-ethnic study of atherosclerosis. Atherosclerosis243(1), 314–319 (2015).
  • Alagona C , SoroA, YlitaloK, SalonenR, SalonenJT, TaskinenMR. A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families. Atherosclerosis165(2), 309–316 (2002).
  • Tiozzo E , GardenerH, HudsonBIet al. Subfractions of high-density lipoprotein-cholesterol and carotid intima-media thickness: the northern Manhattan study. Stroke47(6), 1508–1513 (2016).
  • Neugarten J , AcharyaA, SilbigerS. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol.11(2), 319–329 (2000).
  • Gandolfo M , VerzolaD, SalvatoreFet al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol. Nefrol. 56(1), 1–14 (2004).
  • Suzuki H , KondoK. Chronic kidney disease in postmenopausal women. Hypertens. Res.35(2), 142–147 (2012).
  • Ahmed S , RameshS. Sex hormones in women with kidney disease. Nephrol. Dial. Transplant.31(11), 1787–1795 (2016).
  • Barton M . Cholesterol and atherosclerosis: modulation by oestrogen. Curr. Opin. Lipidol.24(3), 214–220 (2013).
  • Jafar T , SchmidC, StarkPet al. The rate of progression of renal disease may not be slo wer in women compared with men: a patient-level meta-analysis. Nephrol. Dial. Transplant.18(10), 2047–2053 (2003).
  • Shanley PF . The pathology of chronic renal ischemia. Semin. Nephrol.16(1), 21–32 (1996).
  • Fu Q , ColganS, ShelleyC. Hypoxia: the force that drives chronic kidney disease. Clin. Med. Res.14(1), 15–39 (2016).
  • McMahon GM , PreisSR, HwangSJ, FoxCS. Mid-adulthood risk factor profiles for CKD. J. Am. Soc. Nephrol.25(11), 2633–2641 (2014).
  • Pickering JW , EndreZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin. J. Am. Soc. Nephrol.7(8), 1355–1364 (2012).
  • Cook NR . Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation115(7), 928–935 (2007).
  • Pencina M , D’AgostinoR, SteyerbergE. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med.30(1), 11–21 (2011).
  • Pencina MJ , D’Agostino RB Sr., D’Agostino RB Jr., VasanRS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med.27(2), 157–172 (2008).
  • Jiang B , ZhengY, ChenYet al. Age and gender-specific distribution of metabolic syndrome components in east China: role of hypertriglyceridemia in the SPECT-China study. Lipids Health Dis.17(1), 92 (2018).
  • Stefanska A , BergmannK, SypniewskaG. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv. Clin. Chem.72, 1–75 (2015).
  • Park YW , ZhuS, PalaniappanL, HeshkaS, CarnethonMR, HeymsfieldSB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med.163(4), 427–436 (2003).
  • Menke A , CasagrandeS, GeissL, CowieCC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA314(10), 1021–1029 (2015).
  • Fletcher B , GulanickM, LamendolaC. Risk factors for Type 2 diabetes mellitus. J. Cardiovasc. Nurs.16(2), 17–23 (2002).
  • Hara S , KobayashiN, SakamotoKet al. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am. J. Pathol.185(8), 2118–2131 (2015).
  • Matsumoto T , KobayashiT, KamataK. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr. Med. Chem.14(30), 3209–3220 (2007).
  • Saito T , OotakaT, SatoHet al. Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J. Pathol.170(2), 179–185 (1993).
  • Hattori M , HoritaS, YoshiokaT, YamaguchiY, KawaguchiH, ItoK. Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am. J. Kidney Dis.30(5), 632–638 (1997).
  • Abrass C . Cellular lipid metabolism and the role of lipids in progressive renal disease. Am. J. Nephrol.24(1), 46–53 (2004).
  • Wang L , CuiL, WangYet al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int. J. Epidemiol.44(2), 689–699 (2015).
  • Fox CS , PencinaMJ, MeigsJB, VasanRS, LevitzkyYS, D’AgostinoRB, Sr. Trends in the incidence of Type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation113(25), 2914–2918 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.